Lucy Scientific Discovery Inc (LSDI)
0.94
+0.07
(+8.05%)
USD |
NASDAQ |
May 28, 16:00
0.87
-0.07
(-7.45%)
After-Hours: 20:00
Lucy Scientific Discovery Enterprise Value: 2.584M for May 28, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 28, 2024 | 2.584M |
| May 24, 2024 | 2.460M |
| May 23, 2024 | 2.937M |
| May 22, 2024 | 3.078M |
| May 21, 2024 | 3.149M |
| May 20, 2024 | 3.202M |
| May 17, 2024 | 3.502M |
| May 16, 2024 | 3.731M |
| May 15, 2024 | 1.825M |
| May 14, 2024 | 2.108M |
| May 13, 2024 | 2.222M |
| May 10, 2024 | 2.213M |
| May 09, 2024 | 2.324M |
| May 08, 2024 | 2.337M |
| May 07, 2024 | 2.266M |
| May 06, 2024 | 2.342M |
| May 03, 2024 | 2.371M |
| May 02, 2024 | 2.349M |
| May 01, 2024 | 2.496M |
| April 30, 2024 | 2.393M |
| April 29, 2024 | 2.293M |
| April 26, 2024 | 2.266M |
| April 25, 2024 | 2.460M |
| April 24, 2024 | 2.510M |
| April 23, 2024 | 2.778M |
| Date | Value |
|---|---|
| April 22, 2024 | 2.919M |
| April 19, 2024 | 2.902M |
| April 18, 2024 | 3.069M |
| April 17, 2024 | 2.813M |
| April 16, 2024 | 2.866M |
| April 15, 2024 | 2.937M |
| April 12, 2024 | 3.113M |
| April 11, 2024 | 3.228M |
| April 10, 2024 | 3.096M |
| April 09, 2024 | 3.078M |
| April 08, 2024 | 3.184M |
| April 05, 2024 | 3.184M |
| April 04, 2024 | 3.184M |
| April 03, 2024 | 3.254M |
| April 02, 2024 | 3.043M |
| April 01, 2024 | 3.291M |
| March 28, 2024 | 3.382M |
| March 27, 2024 | 3.272M |
| March 26, 2024 | 3.237M |
| March 25, 2024 | 3.325M |
| March 22, 2024 | 3.360M |
| March 21, 2024 | 3.343M |
| March 20, 2024 | 3.219M |
| March 19, 2024 | 3.184M |
| March 18, 2024 | 3.325M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.825M
Minimum
May 15 2024
58.16M
Maximum
Feb 15 2023
11.46M
Average
8.053M
Median
Enterprise Value Benchmarks
| Rimrock Gold Corp | -- |
| CeCors Inc | -- |
| InMed Pharmaceuticals Inc | -5.198M |
| Venus Concept Inc | 75.63M |
| Juva Life Inc | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.620M |
| Revenue (Quarterly) | 0.0097M |
| Total Expenses (Quarterly) | 0.8722M |
| EPS Diluted (Quarterly) | -1.484 |
| Gross Profit Margin (Quarterly) | 60.06% |
| Profit Margin (Quarterly) | -27.05K% |
| Earnings Yield | -753.7% |